| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |